Final Programme

Instructions for Speakers

28/04/2007

10.00 - 20.00   Registration
     
15.30 - 17.00   WorldWIDE Satellite Symposium
Orange Hall
Natural approaches to improving blood glucose control: a hormonal focus on Type 2 diabetes
     
17.15 - 17.30   Opening Ceremony
Plenary Hall
     
17.30 - 18.15   EJE Prize Lecture
Plenary Hall
Chairs: P. Beck-Peccoz (Italy) & I. Gerendai (Hungary)
EJE1 Cortisol and cardiovascular disease
B. R. Walker (United Kingdom)
     
18.15 - 19.00   Geoffrey Harris Prize Lecture
Plenary Hall
Chairs: S. W. J. Lamberts (The Netherlands) & L. Martini (Italy)
GH1 Neuroendocrine control of steroid biosynthesis within the hypothalamus
H. Vaudry (France)
     
19.00 - 21.00   Welcome Reception - A taste of Hungary (wine and cheese party with music on-site)
     

29/04/2007

08.00 - 08.45   Plenary Lecture 1
Plenary Hall
Chairs: P. Bouchard (France) & I. Huhtaniemi (Finland)
PL1 Reading beyond the sequence- the plasticity of the LH/CG-LH receptor system
J. Gromoll (Germany)
     
08.45 - 10.25   Symposium 1 - Clinical: Hypopituitarism
Orange Hall
Chairs: J. Jorgensen (Denmark) & V. Popovic (Serbia)
08:45 S1.1 Traumatic brain injury-induced hypopituitarism: whom and when to test?
C. J. Thompson (Ireland)
09:10 S1.2 Morbidity and mortality
B. A. Bengtsson (Sweden)
09:35 S1.3 Hypocorticotropism
S. Tsagarakis (Greece)
10:00 S1.4 Familial neurogenic diabetes insipidus
S. Rittig (Denmark)
     
08.45 - 10.25   Symposium 2 - Basic to Clinical: Hormones and the brain
Yellow Hall
Chairs: J. Isgaard (Sweden) & M. Motta (Italy)
08:45 S2.1 Thyroid hormone regulation of neural and oligodendrocyte precursors in the mature brain: a possibility for remyelination and neuroprotection
L. Calza (Italy)
09:10 S2.2 Neuroprotective actions of estrogens in the central nervous system
L. M. Garcia-Segura (Spain)
09:35 S2.3 Estrogen receptor signalling and cerebrovascular disease
T. Olsson (Sweden)
10:00 S2.4 Immunesenescence and Steroid Hormones
W. Arlt (United Kingdom)
     
08.45 - 10.25   Symposium 3 - Basic: Signaling and regulation of G-Protein-coupled hormone receptors
Green Hall
Chairs: T. Gudermann (Germany) & A. Spat (Hungary)
08:45 S3.1 Trafficking and signaling of angiotensin receptors
L. Hunyady (Hungary)
09:10 S3.2 Pharmacological chaperones rescue the membrane expression and function of the V1a/V3 receptor
E. Clauser (France)
09:35 S3.3 Functional impact of GPCR heterodimerization
H. Biebermann (Germany)
10:00 S3.4 Ago-allosteric effects of agonist drugs on 7TM receptors and their endogenous hormones - example from the ghrelin receptor
T. W. Schwartz (Denmark)
     
10.25  -  10.55   Coffee Break and Exhibition
     
10.55 - 12.35   Symposium 4 - Clinical: Gastroentereopancreatic endocrine tumors (GEP ET)
Plenary Hall
Chairs: Zs. Tulassay (Hungary) & A. van der Lely (The Netherlands)
10:55 S4.1 Pathological classification of GEP neuroendocrine tumors
M. Papotti (Italy)
11:20 S4.2 Biological, morphological work-up and screening for inherited disease
B. Skogseid (Sweden)
11:45 S4.3 Prognosis of GEP ET
E. Baudin (France)
12:10 S4.4 Therapeutic management of GEP ET
P. Ruszniewski (France)
     
10.55 - 12.35   Symposium 5 - Basic: Novel bioactive peptides: Lessons from animal
Yellow Hall
Chairs: L. De Lecea (USA) & A. Grossman (United Kingdom)
10:55 S5.1 Discovery of novel bioactive peptides: the uniquely important contribution of amphibians to mammalian neuropeptidology
H. Vaudry (France)
11:20 S5.2 Comparative approaches to resolve the complexities of human appetite regulation
D. Larhammar (Sweden)
11:45 S5.3 Bioactive peptides in invertebrate model organisms
L. Schoofs (Belgium)
12:10 S5.4 Somatostatin, cortistatin and their new and old receptors: from comparative to translational endocrinology
J. P. Castaño (Spain)
     
10.55 - 12.35   Oral Communication 1: Thyroid Clinical
Green Hall
Chairs: M. Erdogan (Turkey) & B. Hallehgren (Sweden)
OC1.1 Prevalence of inactivating TSH receptor (TSHR) mutations in a large series of pediatric subjects with non-autoimmune mild hyper-thyrotropinemia (hyperTSH).
Cordella Daniela, De Marco Alessandro, Calebiro Davide, de Filippis Tiziana, Radetti Giorgio, Weber Giovanna, Vigone Maria Cristina, Cappa Marco, Sartorio Alessandro, Busnelli Marta, Bonomi Marco, Chini Bice, Beck-Peccoz Paolo, Persani Luca
Dept of Medical Sciences, University of Milan and Ist. Auxologico Italiano, Milan, Italy Lab of Experimental Endocrinology, IRCCS Ist Auxologico Italiano, Milan, Italy Pediatric Unit, Bolzano, Italy Pediatric Unit, Bambin Gesù Hosp, Rome, Italy
OC1.2 Expression gene profile may be useful for the diagnosis of thyroid malignancies
Piampiani Pamela, Romei Cristina, Cosci Barbara, Vivaldi Agnese, Ciampi Raffaele, Viola David, Bottici Valeria, Giannini Riccardo, Basolo Fulvio, Pinchera Aldo, Elisei Rossella
Department of Endocrinology, University of Pisa, Pisa, Italy Department of Oncology, University of Pisa, Pisa, Italy
OC1.3 Persistence of Decreased Peripheral B Lymphocytes after Rituximab Treatment is Associated to Inactive Disease in Patients with Thyroid-Associated Ophthalmopathy
Campi Irene, Vannucchi Guia, Covelli Danila, Bonara Paola, Currò Nicola, Dazzi Davide, Pirola Giacinta, Rossi Stefania, Guastella Claudio, Beck-Peccoz Paolo, Salvi Mario
Endocrine Unit Department of Medical Science, Fondazione Policlinico IRCCS, University of Milan, Milan, Italy Internal Medicine, Fondazione Policlinico IRCCS, University of Milan, Milan, Italy Ophthalmology, Fondazione Policlinico IRCC, University of Milan, Milan, Italy Internal Medicine, Ospedale di Fidenza, Fidenza, Italy
OC1.4 A novel tyrosine-kinases selective inhibitor with anti-tumoral efficacy (Sunitinib) induces a block in iodine uptake and transient hypothyroidism
Mannavola Deborah, Vannucchi Guia, Carletto Marco, Longari Virgilio, Bertuelli Rossella, Coco Paola, Casali Paolo, Beck-Peccoz Paolo, Fugazzola Laura
Endocrine Unit, Dept. of Medical Sciences, University of Milan, Fondazione Policlinico IRCCS , Milan, Italy Nuclear Medicine Unit, Fondazione Policlinico IRCCS, Milan, Italy Dept. of Oncology, Istituto Nazionale dei Tumori, Milan, Italy
OC1.5 CTLA- 4 Gene Polymorphisms and Autoimmune Thyroid Diseases: Meta-analyses of Published and Individual-level Data
Kavvoura Fotini, Akamizu Takashi, Awata Takuya, Ban Yoshiyuki, Chistiakov Dimitry, Frydecka Irena, Ghaderi Abbas, Gough Stephen, Hiromatsu Yuji, Ploski Rafal, Wang Pei-Wen, Ban Yoshio, Bednarczuk Tomasz, Chistiakova Emma, Chojm Marcin, Heward Joanne, Hiratani Hitomi, Juo Suh-Hang Hank, Karabon Lidia, Katayama Shigehiro, Kurihara Susumu, Liu Rue-Tsuan, Miyake Ikuyo, Omrani Gholam-Hossein, Pawlak Edyta, Taniyama Matsuo, Tozaki Teruaki, Ioannidis John P.A.
Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece Translational Research Center, Kyoto University Hospital, Kyoto University School of Medicine, Kyoto, Japan Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical University, Saitama, Japan Third Department of Internal Medicine Showa University School of Medicine, Tokyo, Japan
OC1.6 Sensitization against Soybean may induce an increase in the levels of anti-thyroid peroxidase antibodies in thyroid autoimmunity
Molnár Ildikó
Kenézy County and Teaching Hospital , Debrecen, Hungary
OC1.7 Pregnant women on thyroxine substitution are often dysregulated in early pregnancy
Hallengren Bengt, Lantz Mikael, Andreasson Bengt,
Department of Endocrinology, Malmö University Hospital, Malmö, Sweden Department of Pediatrics, Malmö University Hospital, Malmö, Sweden Department of Obstetrics and Gynecology, Malmö University Hospital, Malmö, Sweden
     
10.55 - 12.35   Oral Communication 2: Bone & Calcium Metabolism
Brown Hall
Chairs: J. M. Kaufman (Belgium) & P. Lakatos (Hungary)
OC2.1 Effect of Once-Yearly Infusion of Zoledronic Acid 5 mg in Postmenopausal Women with Osteoporosis
Eastell Richard, Lakatos Peter, Black Dennis, Boonen Steven, Cosman Felicia, Cumings Steven, Delmas Pierre, Eriksen Erik Fink, Leung Ping Chung, Man Zulema, Mesenbrink Peter, Reid Ian, Cauley Jane
University of Sheffield, Sheffield, United Kingdom Semmelweis University, Budapest, Hungary University of California, San Francisco, San Francisco, CA, United States Leuven University Center for Metabolic Bone Diseases, Leuven, Belgium
OC2.2 Role of IGF System on the Regulation of Osteoblast Aromatase Activity In Vitro
Palermo Claudia, Arvigo Marica, Minuto Francesco
Department of Endocrinological & Metabolic Sciences and Center of Excellence for Biomedical Research, University of Genoa;, Genoa, Italy
OC2.3 Clinical and biochemical differences in patients affected with sporadic and type 1 multiple endocrine neoplasia (MEN) related primary hyperparathyroidism.
Eller-Vainicher Cristina, Massironi Sara, Peracchi Maddalena, Persani Luca, Beck-Peccoz Paolo, Spada Anna, Corbetta Sabrina
Endocrine Unit, Medical Sciences Department, University of Milan, Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena IRCCS, Milan, Italy Gastroenterology Unit, Department of Medical Sciences, University of Milan, Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena IRCCS, Milan, Italy Lab of experimental endocrinology, Department of Medical Sciences, University of Milan, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy Endocrinology and Diabetology Unit, Department of Medical-Surgical Sciences, University of Milan, Policlinico San Donato IRCCS, San Donato, Milan, Italy
OC2.4 Assessment of Prevalent Vertebral Deformities In Morphometric X-Ray Absorptiometry
Skowronska-Jozwiak Elzbieta, Pludowski Pawel, Karczmarewicz Elzbieta, Lewinski Andrzej, Lorenc Roman
Department of Endocrinology & Metabolic Diseases, The Medical University of Lodz, Lodz, Poland Department of Biochemistry and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland
OC2.5 Effect of gonadal status on baseline and after rhGH treatment prevalence of spinal deformities in adult patients with growth hormone deficiency (GHD)
Mazziotti Gherardo, Bianchi Antonio, Bonadonna Stefania, Nuzzo Monica, Cimino Vincenzo, Fusco Alessandra, De Marinis Laura, Giustina Andrea
Department of Internal Medicine, University of Brescia, Brescia, Italy Department of Endocrinology, Catholic University, Rome, Italy., Rome, Italy
OC2.6 Sunlight exposure and vitamin D supplementation at the institutionalized elderly – effects on calcium and bone metabolism
Bottermann Peter, Branisteanu Dumitru, Mogos Voichita, Zbranca Eusebie
University of Medicine and Pharmacy "Gr.T.Popa", Iasi, Romania Technical University, Munchen, Germany
OC2.7 Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells
Horie-Inoue Kuniko, Ichikawa Tomoe, Inoue Satoshi
Research Center for Genomic Medicine, Saitama Medical University, Hidaka-shi, Saitama, Japan Graduate School of Medicine, the University of Tokyo, Bunkyo-ku, Tokyo, Japan
     
12.35 - 14.00   Novartis Satellite Symposium – Acromegaly – basic science and not clinical research will determine the future: a debate
Orange Hall
Chair: M. Sheppard (United Kingdom)
     
14.00 - 15.00   Poster session & Lunch
Comparative Endocrinology P1 - P7
Cytokines and Growth Factors P8 - P23
Diabetes & Cardiovascular P24 - P59
Endocrine Tumors & Neoplasia P97 - P138
Growrh & Development P180 - P189
Obesity & Metabolism P190 - P228
Signal Transduction P269 - P274
Steroid Receptors P275 - P285
Thyroid P286 - P339
     
14.30 - 15.30   Meet the Expert 01 - Clinical: Graves' Ophthalmopathy
Plenary Hall
ME1 Choosing and timing treatment options in Graves' Orbitopathy (GO)
W. van den Bosch (The Netherlands)
ME1 Endocrine Orbitopathy
Cs. Balázs (Hungary)
     
14.30 - 15.30   Meet the Expert 02 - Clinical: Mineralocoticoid Hypertension
Yellow Hall
ME2 Mineralocorticoid Hypertension
M. Mannelli (Italy)
     
14.30 - 15.30   Meet the Expert 03 - Basic to Clinical: Fetal programming by andorgen excess
Green Hall
ME3 Meet the Expert 03 - Fetal programming by androgen excess
A. Tsatsoulis (Greece)
     
14.30 - 15.30   Meet the Expert 04 - Clinical: Intensive insulin treatment in ICU
Blue Hall
ME4 Intensive insulin treatment in ICU
T. Pieber (Austria)
     
14.30 - 15.30   Meet the Expert 09 - Clinical: Turner Syndrome
Brown Hall
ME9 Turner Syndrome
E. Malecka-Tendera (Poland)
     
14.30 - 15.30   Meet the Expert 10 - Clinical: Indications, management and follow-up of bariatric surgery patients
Room III
ME10 Indications, management and follow up of bariatric surgery
B. Burguera (Spain) & M. Fried (Czech Republic)
     
14.30 - 15.30   Meet the Expert 11 - Basic to Clinical: Thyroid echocolordoppler
Orange Hall
ME11 Thyroid echocolordoppler
P. Vitti (Italy)
     
14.30 - 15.30   Meet the Expert 12 - Clinical: Stem cell therapy in endocrinology: reality and challenges
Room II
ME12 Stem Cell Therapy in Endocrinology: Reality and Challenges
M. Kassem (Denmark)
     
15.30 - 16.00   Tea Break & Exhibition
     
16.00 - 17.45   Symposium 6 - Basic to Clinical: Diabetes and Insulin
Plenary Hall
Chairs: S. Del Prato (Italy) & V. Pirags (Latvia)
16:00 S6.1 Perspectives of islet cells transplantations
B. Keymeulen (Belgium)
16:25 S6.2 Cytokines as pathogenetic effectors in type 1 and type 2 diabetes
T. Mandrup-Poulsen (Denmark)
16.50 S6.3 GLP-1 as a drug target
T. Vilsbøll (Denmark)
17:15 S6.4 Engineering beta cells to recover insulin function
B. Soria (Spain)
     
16.00 - 17.45   Symposium 7 - Basic: Thyroid Cell Biology
Yellow Hall
Chairs: C. Alvarez (Spain) & M. Nilsson (Sweden)
16:00 S7.1 New insights from zebrafish: The molecular and cellular base of thyroid development
K. Rohr (Germany)
16:25 S7.2 Involvement of cardiovascular development and non-cell autonomous signaling in mouse thyroid organogenesis
H. Fagman (Sweden)
16:50 S7.3 Thyroglobulin deposition and cathepsin-dependent Tg mobilization
K. Brix (Germany)
17:15 S7.4 Role of the complex Megalin-RAP in thyroglobulin trafficking
M. Marino (Italy)
     
16.00 - 17.45   Oral Communication 3: Endocrine Tumors & Neoplasia
Green Hall
Chairs: B. Jarzab (Poland) & E. Malecka-Tendera (Poland)
OC3.1 Multiple somatostatin receptor subtypes activation reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
Zatelli Maria Chiara, Piccin Daniela, Tagliati Federico, Ambrosio Maria Rosaria, Bianchi Antonio, Bondanelli Marta, Schmid Herbert A, Scanarini Massimo, De Marinis Laura, Maira Giulio, degli Uberti Ettore C
Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies - University of Ferrara , Ferrara, Italy Institute of Endocrinology, Catholic University of Rome, Rome, Italy Novartis Institutes for Biomedical Research, Oncology, Basel, Switzerland Division of Neurosurgery - Hospital of Padova, Padova, Italy
OC3.2 Adrenal lessions in multiple endocrine neoplasia type 1: data from the French group for the study of endocrine tumors (GTE)
Gatta Blandine, Monsaingeon Maud, Goudet Pierre, Murat Arnaud, Niccoli-Sire Patricia, Calender Alain, Rohmer Vincent, Chabre Olivier, Tabarin Antoine
Dpt Endocrinology, Bordeaux, France Dpt Surgery, Dijon, France Dpt Endocrinology, Nantes, France Dpt Endocrinology, Grenoble, France
OC3.3 BMP dependent effects on adrenal tumorigenesis and function
Johnsen Inga, Kaufmann Sarah, Spady Lilia, Beuschlein Felix
Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Medical Clinic, University Hospital Innenstadt, Ludwig Maximilians University, Munich, Germany
OC3.4 RET mutation - Tyr791Phe - the genetic cause of different diseases derived from neural crest
Vaclavikova Eliska, Dvorakova Sarka, Vlcek Petr, Skaba Richard, Bilek Radovan, Bendlova Bela
Dept. of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic Dept. of Nuclear Medicine and Endocrinology, 2nd Faculty of Medicine, Charles University and Hospital Motol, Prague, Czech Republic Dept. of Pediatric Surgery, 2nd Faculty of Medicine, Charles University and Hospital Motol, Prague, Czech Republic
OC3.5 [123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience
Hahner Stefanie, Stuermer Andrea, Fassnacht Martin, Kreissl Michael, Reiners Christoph, Beuschlein Felix, Zink Martina, Zolle Ilse, Schirbel Andreas, Allolio Bruno
University of Wuerzburg, Dept. of Endocrinology and Diabetology, Wuerzburg, Germany University of Wuerzburg, Dept. of Nuclear Medicine, Wuerzburg, Germany University of Munich, LMU, Division of Endocrine Research, Munich, Germany University of Vienna, Ludwig-Boltzmann-Institute of Nuclear Medicine, Vienna, Austria
OC3.6 ERß-Specific Transcriptional Profile in Colon Cancer
Martineti Valentina, Mascherini Massimiliano, Mavilia Carmelo, Carbonell Sala Silvia, Tognarini Isabella, Azzari Chiara, Stefanini Federico Mattia, Tonelli Francesco, Brandi Maria Luisa
Department of Internal Medicine, School of Medicine, University of Florence, Florence, Italy Department of Clinical Physiopathology, School of Medicine, University of Florence, Florence, Italy Department of Pediatrics, School of Medicine, University of Florence, Florence, Italy Department of Statistics, University of Florence, Florence, Italy
OC3.7 Fasting Insulin Levels are Predictors of Colonic Lesions in Patients with Acromegaly: an Observational, Open, Prospective Study in 189 Patients
Colao Annamaria, Pivonello Rosario, Galdiero Mariano, Auriemma Renata S., Ferone Diego, Marzullo Paolo, Lombardi Gaetano
Department of Molecular and Clinical Endocrinology and Oncology, section of Endocrinology, University “Federico II” of Naples, Naples, Italy Department of Endocrine and Metabolic Diseases, University of Genova, Genova, Italy Section of Endocrinology, Auxologic Institute of Verbania, Verbania, Italy
     
16.00 - 17.45   Oral Communication 4: Neuroendocrinology Basic
Brown Hall
Chairs: J. P. Castaño (Spain) & M. Malagon (Spain)
OC4.1 Organismal, cellular and molecular evolution of water balance regulation in vertebrates : the amphibian hinge
Acher Roger, Chauvet Jacqueline, Rouillé Yves
University Paris VI, Paris, France
OC4.2 Growth Hormone-Releasing Hormone (GHRH) exerts protective effects on adult rat hippocampal progenitor cells.
Destefanis Silvia, Johansson Inger, Aberg David, Granata Riccarda, Ghigo Ezio, Isgaard Jorgen
University of Turin, Turin, Italy Sahlgrenska University, Goteborg, Sweden
OC4.3 Absence of germline AIP mutations in early onset sporadic somatotropinomas
Gomes Leonor, Prazeres Hugo, Paiva Isabel, Ribeiro Cristina, Rebelo Olinda, Martins Teresa, Lacerda Manuela, Carvalheiro Manuela
Serviço de Endocrinologia, Diabetes e Metabolismo dos Hospitais da Universidade de Coimbra, Coimbra, Portugal Laboratório de Patologia Molecular do Serviço de Anatomia Patológica do Centro Regional de Oncologia de Coimbra do Instituto Português de Oncologia, EPE, Coimbra, Portugal Serviço de Anatomia Patológica dos Hospitais da Universidade de Coimbra, Coimbra, Portugal
OC4.4 Is there a role for dopamine d2 receptor gene polymorphisms in determining cabergoline sensitivity in prolactin-secreting pituitary adenomas?
Filopanti Marcello, Barbieri Anna Maria, Angioni Rita, Lania Andrea, Mantovani Giovanna, Spada Anna, Beck-Peccoz Paolo
Endocrine Unit, Dept. Medical Sciences, University of Milan; Fondazione Ospedale Maggiore Policlinico IRCCS, Milano, Italy
OC4.5 Lack of nuclear Hes1 expression coincides with transformation of endocrine pancreatic cells in Men1 knock out mice
Johansson Térèse, Halin Lejonklou Margareta, Skogseid Britt
Institution of Medical Sciences, Uppsala, Sweden
OC4.6 Metabolic Abnormalities in Patients with Adrenal Adenomas May Be Associated with BclI Polymorphism in the Glucocorticoid Receptor (GR) Gene and Expression of Tumor-Specific Hsp70 Isoforms
Damjanovic Svetozar, Antic Jadranka, Beleslin Bojana, Ognjanovic Sanja, Vignjevic Jovana, Petakov Milan, Macut Djuro, Paunovic Ivan, Isailovic Tatjana, Popovic Bojana, Bozic Ivana
Institute for endocrinology, diabetes and metabolic diseases, Belgrade, Serbia
OC4.7 Function and Evolution of GHRH, PACAP and PRP in Vertebrates
Chow Billy KC, Siu Francis KY, Tam Janice KV, Lee Leo TO
University of Hong Kong, Pokfulam, HK, SAR, China
     
17.45 - 18.30   Plenary Lecture 2
Plenary Hall
Chairs: R. Bouillon (Belgium) & R. Gaillard (Switzerland)
PL2 Reciprocal regulations of bone and energy metabolisms
G. Karsenty (USA)
     
18.30 - 20.00   Pfizer Satellite Symposium - Medical Treatment of Acromegaly - current evidence and new insights
Orange Hall
Chair: P. Trainer (United Kingdom)
     
20.00 -    Take it easy party
     

30/04/2007

08.00 - 08.45   Plenary Lecture 3
Plenary Hall
Chairs: A. Pinchera (Italy) & M. Sheppard (United Kingdom)
PL3 Importance of transporters for cellular entry of thyroid hormone
T. J. Visser (The Netherlands)
     
08.45 - 10.25   Symposium 08 - Clinical: Advances in adrenal hypersecretory disorders
Yellow Hall
Chairs: B. Allolio (Germany) & Z. Zheng-pei (China)
08:45 S8.1 Autocrine-paracrine pathways in primary adrenal disorders
H. Lefebvre (France)
09:10 S8.2 Carney Complex and Primary Pigmented Nodular Adrenocortical Disease
J. Bertherat (France)
09:35 S8.3 Diagnosis and prevalence of primary aldosteronism
G. P. Rossi (Italy)
10:00 S8.4 Adrenocortical carcinoma: current and future therapeutic options
M. Fassnacht (Germany)
     
08.45 - 10.25   Symposium 09 - Clinical: Imaging in endocrinology
Green Hall
Chairs: P. Lind (Austria) & J. Marek (Czech Republic)
08:45 S9.1 PET in diagnostics of metabolic alterations and endocrinological tumours
P. Nuutila (Finland)
09:10 S9.2 Micro-, nano- and molecular imaging of bone
C. C. Gluer (Germany)
09:35 S9.3 New tracers for neuroendocrine tumors
M. P. M. Stokkel (The Netherlands)
10:00 S9.4 Echoendoscopy for the diagnosis of pancreatic endocrine tumors
C. De Angelis (Italy)
     
08.45 - 10.25   Symposium 10 - Basic: GH & prolactin at their targets
Orange Hall
Chairs: F. Casanueva (Spain) & C. Strasburger (Germany)
08:45 S10.1 Cellular control mechanisms for GH sensitivity
G. J. Strous (The Netherlands)
09:10 S10.2 GH receptor signalling
G. Norstedt (Sweden)
09:35 S10.3 Gene expression profiling of the antiangiogenic factor 16K human Prolactin (hPRL) on endothelial cells underlines the key role of NF-kB and reveals novel mechanisms of action
J. Martial (Belgium)
10:00 S10.4 Development of human prolactin receptor antagonists
V. Goffin (France)
     
10.25 - 10.55   Coffee Break & Exhibition
     
10.55 - 12:35   Symposium 11 - Basic to Clinical: Polycystic ovary syndrome
Plenary Hall
Chairs: F. Kelestimur (Turkey) & D. Micic (Serbia)
10:55 S11.1 The CAG Repeat Polymorphism of the Androgen Receptor Gene is an independent Risk Factor for Polycystic Ovary Syndrome (PCOS)
A. Schuering (Germany)
11:20 S11.2 Genetic Markers of Polycystic Ovary Syndrome (PCOS)
J. Laven (The Netherlands)
11:45 S11.3 Hyperandrogenism and Metabolic Syndrome (MBS) in Polycystic Ovary Syndrome (PCOS)
A. Dunaif (USA)
12:10 S11.4 Individual pharmacological therapy for polycystic ovary syndrome: lessons from the phenotype
R. Pasquali (Italy)
     
10.55 - 12.35   Symposium 12 - Basic: Hypothalamic network controlling food intake
Orange Hall
Chairs: U. Pagotto (Italy) & M. Palkovits (Hungary)
10:55 S12.1 Processing of metabolic signals in the hypothalamus: the integrative role of the paraventricular nucleus
Z. Liposits (Hungary)
11:20 S12.2 Neurotransmitter content of orexigenic and anorexigenic neurones
B. Meister (Sweden)
11:45 S12.3 The picture of the hypothalamus is becoming clearer: new concept of cross-talk
T. Horvath (USA)
12:10 S12.4 Whom is insulin in the brain speaking to?
J. Bruening (Germany)
     
10.55 - 12.35   Oral Communication 5: Thyroid Basic
Green Hall
Chairs: M. Alevizaki (Greece) & W. Wiersinga (The Netherlands)
OC5.1 Structure-function of glycoprotein hormones using site-directed mutagenesis and gene transfer: Designing new agonists and antagonists
Fares Fuad, Azam Naiel, Bar-Shalom Rinat, Kraiem Zaki
Carmel medical Center and the Faculty of Medicine, Technion-israel Institute of Trechnology, Haifa, Israel
OC5.2 Tyroglobulin (Tg) depletion in receptor associated protein (RAP) KO mice is due to a reduction of Tg aggregates
Lisi Simonetta, Botta Roberta, Pinchera Aldo, Marcocci Claudio, Marinò Michele
Department of Endocrinology, University of Pisa, Pisa, Italy
OC5.3 Polarized plasma membrane targeting of the Na+/I- symporter (NIS) is regulated by its carboxy terminus
Dohan Orsolya, Portulano Carla, Ginter Chris, Carrasco Nancy
Albert Einstein College of Medicine, Bronx, New York, United States Institute of Experimental Medicine Hungarian Academy of Sciences and Szent Rokus Hospital and Institutions, Budapest, Hungary
OC5.4 BRAFV600E mutations but not RET/PTC rearrangements are correlated with a lower expression of NIS mRNA expression in papillary thyroid cancer (PTC)
Romei Cristina, Piampiani Pamela, Faviana Pinuccia, Basolo Fulvio, Bottici Valeria, Sculli Mariangela, Berti Piero, Materazzi Gabriele, Pinchera Aldo, Elisei Rossella
Department of Endocrinology, University of Pisa, Pisa, Italy Department of Surgery, University of Pisa, Pisa, Italy Department of Oncology, University of Pisa, Pisa, Italy
OC5.5 Transcriptional Regulation of Human Type 2 Deiodinase and Chorionic Gonadotropin Genes in Human Placenta: Emerging Evidence of a Common Promoter Code
Canettieri Gianluca, Santaguida Maria Giulia, Franchi Antonella, Della Guardia Michele, Gulino Alberto,
Centanni Marco University of Rome “La Sapienza”- Polo Pontino, Latina, Italy
OC5.6 A Crucial Role of Interleukin- 6 in the Pathogenesis of Thyrotoxicosis-related Disturbances of Bone Turnover in Mice
Mysliwiec Janusz, Zbucki Robert, Winnicka Maria Malgorzata, Sawicki Boguslaw, Nikolajuk Agnieszka, Kaminski Karol, Musial Wlodzimierz, Mysliwiec Piotr, Bondyra Zofia, Walecki Jerzy, Gorska Maria
Dept. of Endocrinology, Diabetology and Internal Diseases, Bialystok, Poland Dept. of General and Experimental Pathology, Bialystok, Poland Dept. of Histology and Embryology, Bialystok, Poland Dept. of Cardiology, Bialystok, Poland
OC5.7 The 1188A/C polymorphism of IL-12 gene in Graves’ disease.
Wawrusiewicz-Kurylonek Natalia, Gorska Maria, Mysliwiec Janusz, Kretowski Adam Jacek
Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
     
10.55 - 12.35   Oral Communication 6: Cardiovascular Endocrinology
Brown Hall
Chairs: F. Mantero (Italy) & T. Olsson (Sweden)
OC6.1 Growth hormone-releasing hormone prevents cardiomyocyte apoptosis and activates pi3k/akt, erk1/2 and creb signaling pathways
Granata Riccarda, Trovato Letizia, Destefanis Silvia, Settanni Fabio, Annunziata Marta, Gallo Davide, Ghigo Ezio
Dept. Internal Medicine, Div. Endcocrinology and Metabolism, University of Turin, Turin, Italy
OC6.2 Testosterone replacement therapy attenuates fatty streak formation and improves the high-density lipoprotein cholesterol profile in the Tfm mouse: an effect which is independent of the classical androgen receptor
Nettleship Joanne E, Jones Richard D, Channer Kevin S, Jones H. T
Hormone and Vascular Biology Group, Academic Unit of Diabetes, Endocrinology & Metabolism, Division of Genomic Medicine, University of Sheffield Medical School, Beech Hill Road , Sheffield, S10 2RX, United Kingdom Department of Cardiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Trust, Glossop Road, Sheffield, S10 2JF, United Kingdom
OC6.3 Plasma brain natriuretic peptide (BNP) levels predict acute right ventricular dysfunction in pulmonary embolism – prospective study on 70 patients
Pascu Alina Mihaela, Radoi Mariana, Coculescu Mihail
"Transilvania" University, Faculty of Medicine, Department of Pathophysiology, Cardiology Clinic, Brasov, Romania "Transilvania" University, Faculty of Medicine, Department of Internal Medicine, Cardiology Clinic, Brasov, Romania "Carol Davila" University of Medicine and Pharmacy, Department of Endocrinology, "C.I. Parhon" Institute of Endocrinology, Bucuresti, Romania
OC6.4 Carotid IMT and stiffness, aortic stiffness and pulse pressure: association with hormone therapy in postmenopausal women: baseline findings from the CASHMERE trial
Simon T., Boutouyrie P., Christin-Maitre S., Gompel A., Joanides R., Kearny-Schwartz A., Kuntz Ch., Laurent S., Pannier B., Pornel B., H. Struijker-Boudier H., Thuilliez Ch., Van Bortel L., Zannad F., Pithois-Merli I., Jaillon P.
Saint Antoine-UPMC ParisVI university-Hospital, paris, France HEGP-Paris V-University Hospital, paris, France Hotel Dieu-Paris V-University Hospital, paris, France CHU Rouen, Rouen, France
OC6.5 Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression in mononuclear blood cells: A randomized trial in healthy men
Gouni-Berthold Ioanna, Berthold Heiner, Gylling Helena, Ko Yon, Plat Jogchum, Krone Wilhelm
Department of Internal Medicine II, University of Cologne, Cologne, Germany Drug Comission of the German Medical Association, Berlin, Germany Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland Medical Poliklink, University of Bonn, Bonn, Germany
OC6.6 The Importance Of The Taaaa(n) Alleles At The Shbg Gene Promoter For The Severity Of Cardiovascular Disease In Women
Saltiki Katerina, Xita Nectaria, Cimponeriu Adriana, Kanakakis Ioannis, Mantzou Emily, Doukas Charalambos, Georgiou Ioannis, Alevizaki Maria
Endocrine Unit, Evgenidion Hospital, Athens University School of Medicine , Athens, Greece Dept Medical Therapeutics, Alexandra Hospital, Athens University School of Medicine, Athens, Greece Medical Genetics Unit, Dept of Obstetrics and Gynaecology, Medical School, University of Ioannina, Ioannina, Greece
OC6.7 Evaluation of Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist, in “Asymptomatic” Hyponatremia: Effects on Sodium Concentration and Patient Reported Health Outcomes
Gross Peter, Verbalis Joseph, Decaux Guy, Ouyang John, Hobart Mary, Orlandi Cesare, Czerwiec Frank
Universitätsklinikum Carl Gustav Carus, Dresden, Germany Georgetown University, Washington, DC, United States Otsuka Maryland Research Institute, Rockville, MD, United States Erasme University Hospital, Brussels, Belgium
     
12.35 - 14.00   Pfizer Satellite Symposium - Childhood - onset GHD - consequences for adult life
Orange Hall
Chair: S. Shalet (United Kingdom)
     
14.00 - 15.00   Poster Session & Lunch
Bone & Calcium P389 - P428
Clinical Case Reports & Clinical Practice P430 - P472
Diabetes & Cardiovascular P60 – P96
Neuro-endocrine & pituitary behaviour P519 - P562
Thyroid P340 - P388

     
14.30 - 15.30   Meet the Expert 05 - Clinical: Hirsutism
Orange Hall
ME5 Hirsutism
B. O. Yildiz (Turkey)
     
14.30 - 15.30   Meet the Expert 06 - Clinical: Diagnosis of hypercortisolism
Plenary Hall
ME6 Differential diagnosis of hypercortisolism
M. Krsek (Czech Republic)
     
14.30 - 15.30   Meet the Expert 07 - Basic to Clinical: Endocrine disrupters
Brown Hall
ME7 Endocrine disrupting chemicals: An emerging threat to public health?
H. Jarry (Germany)
     
14.30 - 15.30   Meet the Expert 08 - Basic: Mass spectrometry in endocrinology
Room III
ME8 Mass spectrometry in endocrinology
W. D. Fraser (United Kingdom)
     
14.30 - 15.30   Meet the Expert 09 - Clinical: Turner Syndrome
Room II
ME9 Turner Syndrome
E. Malecka-Tendera (Poland)
     
14.30 - 15.30   Meet the Expert 10 - Clinical: Indication, management and follow-up of bariatric surgery patients
Yellow Hall
ME10 Indications, management and follow up of bariatric surgery
B. Burguera (Spain) & M. Fried (Czech Republic)
     
14.30 - 15.30   Meet the Expert 11 - Basic to Clinical: Thyroid echocolordoppler
Blue Hall
ME11 Thyroid echocolordoppler
P. Vitti (Italy)
     
14.30 - 15.30   Meet the Expert 12 - Basic: Stem cell therapy in endocrinology: reality and challenges
Green Hall
ME12 Stem Cell Therapy in Endocrinology: Reality and Challenges
M. Kassem (Denmark)
     
15.30 - 16.00   Tea break & Exhibition
     
16.00 - 17.45   Symposium 13 - Basic to clinical: Glucocorticosteroids
Plenary Hall
Chairs: J. Julesz (Hungary) & A. Luger (Austria)
16:00 S13.1 Recent developments in nuclear receptor action
J. A. Gustafson (Sweden)
16:25 S13.2 Evaluation of steroid receptor function by gene targeting in mice
G. Schütz (Germany)
16:50 S13.3 The 11-beta hydroxysteroid dehydrogenase story
J. W. Tomlinson (United Kingdom)
17:15 S13.4 Glucocorticoid sensitivity: consequences for the clinic?
J. W. Koper (The Netherlands)
     
16.00 - 17.45   Symposium 14 - Basic: Trojan horses for hormones
Orange Hall
Chairs: J. Köhrle (Germany) & M. Pfeiffer (Slovenia)
16:00 S14.1 Alpha-fetoprotein protects the developing female brain from estrogens
J. Bakker (Belgium)
16:25 S14.2 Role of endocytic receptors in cellular uptake of steroid hormones
T. E. Willnow (Germany)
16:50 S14.3 Hepatic deiodinase activity is dispensable for the maintenance of normal thyroid hormone levels in mice
U. Schweizer (Germany)
17:15 S14.4 IGF-Independent Actions of IGFBPs
J-M. Ricort (France)
     
16.00 - 17.45   Oral Communication 7: Reproduction 1
Green Hall
Chairs: J. Gromoll (Germany) & C. Krausz (Italy)
OC7.1 Kallmann syndrome: mutations in the genes encoding prokineticin-2 (PROK2) and prokineticin receptor-2 (PROKR2)
Dodé Catherine, Hardelin Jean-Pierre
Institut Cochin, Paris, France
OC7.2 Neuropilin-2 and its ligands are involved in the migration of GnRH-secreting neurons
Cariboni Anna, Rakic Sonja, Hickok Jason, Andrews William, Tischkau Shelley, Maggi Roberto,
Parnavelas John University College London, London, United Kingdom University of Milan, Milan, Italy University of Illinois at urbana-Champaign, Urbana-Champaign, United States
OC7.3 Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men
Ruwanpura Saleela, McLchlan Robert, Meachem Sarah
Prince henry's Institute, Clayton, VIC, Australia Monash university, Clayton, VIC, Australia
OC7.4 Capacitation and acrosome reaction in human ejaculated spermatozoa involve activation of a novel SRC tyrosine kinase
Varano Gabriele, Lombardi Adriana, Forti Gianni, Baldi Elisabetta, Luconi Michaela
University of Florence, Dept. Clinical Physiopathology, Florence, Italy
OC7.5 Estrogens regulate epididymal contractility through RhoA/Rho-Kinase signalling
Filippi Sandra, Morelli Annamaria, Vignozzi Linda, Mancina Rosa, Mungai Sara, Ambrosini Stefano, Vannelli Gabriella Barbara, Forti Gianni, Maggi Mario
University of Florence, Department of Clinical Physiopathology, Andrology Unit, Florence, Italy University of Florence, Department of Clinical Physiopathology, Endocrinology Unit, Florence, Italy University of Florence,Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction, Dep.of Pharmacology and Clinical Physiopathology, Florence, Italy University of Florence, Department of Anatomy, Histology and Forensic Medicine, Florence, Italy
OC7.6 Serum anti-Müllerian hormone levels in men with normo- and oligozoospermia
Tüttelmann Frank, Dykstra Nina, Themmen Axel PN, Visser Jenny, Nieschlag Eberhard, Simoni Manuela
Institute of Reproductive Medicine of the University, Münster, Germany Department of Internal Medicine, Erasmus MC, Rotterdam, Netherlands
OC7.7 Use of atorvastatin, but not simvastatin in men with Type 2 diabetes is associated with lower total testosterone levels with no effect on bioavailable or free testosterone
Stanworth Roger D, Kapoor Dheeraj, Channer Kevin S, Jones T Hugh
Academic Unit of Endocrinology, University of Sheffield, Sheffield, United Kingdom Department of Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley, United Kingdom Faculty for Health and Wellbeing, Sheffield Hallam University, Sheffield, United Kingdom Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
     
16.00 - 17.45   Oral Communication 8: Neuroendocrinology Clinical
Brown Hall
Chairs: A. Galvao-Tiles (Portugal) & S. Tsagarakis (Greece)
OC8.1 Growth Hormone Response during OGTT: The Impact of Assay Method, Gender and BMI on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls
Arafat Ayman M., Möhlig Mathias, Weickert Martin O., Perschel Frank H., Purschwitz Johannes, Spranger Joachim, Strasburger Christian J., Schöfl Christof, Pfeiffer Andreas F.H.
Department of Endocrinology, Diabetes and Nutrition, Charité-University Medicine Berlin, Campus Benjamin Franklin and the German Institute of Human Nutrition, Berlin, Germany Department of Clinical Chemistry and Pathobiochemistry, Charité-University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany Department of Clinical Endocrinology, Charité-University Medicine Berlin, Campus Mitte, Berlin, Germany
OC8.2 Effect of gh receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in acromegalic patients resistant to somatostatin analogues
De Martino Maria Cristina, Auriemma Renata S, Brevetti Gregorio, Galdiero Mariano, De Leo Monica, Lombardi Gaetano, Colao Annamaria, Pivonello Rosario
Departments of Molecular and Clinical Endocrinology and Oncology, "Federico II" University , Naples, Italy Department of Internal Medicine, Division of Cardiovascular and Immunological Sciences, "Federico II" University , Naples, Italy
OC8.3 Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain injury
Schneider Harald J., Croce Chiara G., Corneli Ginevra, Ghigo Ezio, Stalla Günter K., Aimaretti Gianluca
Internal Medicine/Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany Division of Endocrinology and Metabolism, Department of Internal Medicine, Turin, Italy
OC8.4 Idiopatic central hypothyroidism: report of a human natural model of congenital trh receptor (TRHT) absence
Bonomi Marco, Busnelli Marta, Pilotta Alba, Prandi Elena, Maggi Mario, Buzi Fabio, Beck-Peccoz Paolo, Persani Luca
Dept. of Medical Sciences, University of Milan; Istituto Auxologico Italiano IRCCS and Fondazione Ospedale Policlinico IRCCS, Milan, Italy Growth and Development Unit, Children's Hospital , Brescia, Italy Dept. of Physiopathology, University of Florence, Florence, Italy
OC8.5 Inoperable pituitary tumours treated with 90Y-DOTA-TATE – initial results
Kaminski Grzegorz, Szalus Norbert, Zielinski Grzegorz, Podgajny Zbigniew, Zgliczynski Wojciech, Kasperlik-Zaluska Anna, Cyperling-Kaminska Joanna, Dziuk Eugeniusz
Military Institute of Health Services, Warsaw, Poland Medical Center of Postgraduate Education, Warsaw, Poland LIM Medical Center, Warsaw, Poland
OC8.6 Improved glucocorticoid replacement therapy by a novel oral hydrocortisone modified-release tablet
Skrtic Stanko, Lennernäs Hans, Nilsson Anna, Bergthorsdottir Ragnhildur, Hedner Thomas, Johannsson Gudmundur
Dept of Endocrinology, Sahlgrenska University Hospital, Goteborg, Sweden Dept of Clinical Pharmacology, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden Dept of Biopharmacy and Pharmacokinetics, Uppsala University, Uppsala, Sweden
OC8.7 A Single Intravenous Bolus of Dexamethasone for the Diagnosis of Cushing's Syndrome
Munter Gabriel, Kirshner Moriah, Ariel Rosler, Shmuel Shilo, Gil Leibowitz, Benjamin Glaser
Shaare Zedek Medical Center, Jerusalem, Israel 2Endocrinology Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
     
17.45 - 18.30   Plenary Lecture 4
Plenary Hall
Chairs: J. Christiansen (Denmark) & A. Dunaif (USA)
PL4 The Metabolic Syndrome: a cultural exercise or a clinical entity?
S. Del Prato (Italy)
     
18.30 - 20.00   ProStrakan Satellite Symposium - TIMES2 act: Testosterone - improving outcomes in male at-risk populations
Orange Hall
Chair: H. Behre (Germany)
     
20.00 -    Boat Excursion
     

01/05/2007

08.00 - 08:45   Plenary Lecture 5
Plenary Hall
Chairs: B. Halasz (Hungary) & P. Mullis (Switzerland)
PL5 The coordination of circadian timing in brain and peripheral organs
U. Schibler (Switzerland)
     
08.45 - 10.25   Symposium 15 - Basic: Novel bone hormones and regulators
Plenary Hall
Chairs: M. Rogers (United Kingdom)
08:45 S15.1 Sclerostin, an osteocyte-produced regulator of bone formation
S. Papapoulos (The Netherlands)
09:10 S15.2 Hormonal regulation of periosteal bone growth.
D. Vanderschueren (Germany)
09:35 S15.3 Wnt signaling and LRP 5/6 regulation of bone mass
P. Bodine (USA)
10:00 S15.4 Thyroid hormones/TR and bone
G. R. Williams (United Kingdom)
     
08.45 - 10.25   Symposium 16 - Basic to clinical: Immune-endocrine turmoil of pregnancy
Yellow Hall
Chairs: V. Geenen (Belgium) & M. van Hagen (The Netherlands)
08:45 S16.1 Endocrine diseases during pregnancy
R. J. Kaaja (Finland)
09:10 S16.2 Esterol (E4), the forgotten fetal steroid
H. C. Bennink (The Netherlands)
09:35 S16.3 Regulatory T cells in pregnancy
A. C. Zenclussen (Germany)
10:00 S16.4 The effect of pregnancy on immune disease
M. Hazes (The Netherlands)
     
08.45 - 10.25   Symposium 17 - Clinical: Somatostatim receptors in health & disease
Orange Hall
Chairs: L. Hofland (The Netherlands) & J. Wass (United Kingdom)
08:45 S17.1 Pro and contra of SRIF analogue therapy in pituitary tumors
A. J. van der Lely (The Netherlands)
09:00 S17.2 Somatostatin Receptors in Neuroendocrine Tumors
K. Oberg (Sweden)
09:35 S17.3 Peptide receptor therapy
D. J. Kwekkeboom (The Netherlands)
10:00 S17.4 Cortistatin, a multi-functional somatostatin receptor analog
L. de Lecea (USA)
     
10.25 - 10.55   Coffee Break & Exhibition
     
10.55 - 12.35   Symposium 18 - Clinical: Puberty and Hypogonadism
Orange Hall
Chairs: G. Forti (Italy)
10:55 S18.1 Endocrine disorders of puberty
M. Niedziela (Poland)
11:20 S18.2 Role of sex steroids and nitric oxide in male sexual function
V. Rochira (Italy)
11:45 S18.3 Clinical management of Premature Ovarian Failure
S. Christin-Maitre (France)
12:10 S18.4 Gonadal function in ageing men
J. M. Kaufman (Belgium)
     
10.55 - 12.35   Symposium 19 - Basic: Pituitary cell biology
Yellow Hall
Chairs: A. Colao (Italy) & A. Spada (Italy)
10:55 S19.1 Role of the folliculostellate cells
W. Allaerts (The Netherlands)
11:20 S19.2 Signalling in pituitary tumours: the roles of Akt, BRAF, AIP and other novel agents
M. Korbonits (United Kingdom)
11:45 S19.3 Oncogene gsp and Gsα overexpression in pituitary cell biology
A. Barlier (France)
12:10 S19.4 Adipocytokines and pituitary function
M. Malagon (Spain)
     
10.55 - 12.35   Oral Communication 09: Signal Transduction
Green Hall
Chairs: A. Aranda (Spain) & G. Norstedt (Sweden)
OC9.1 Investigation of the role of MRAP in the functional expression of the melanocortin 2 receptor
Cooray Sadani, Metherell Lou, Cheetham Mike, Clark Adrian
William Harvey Research Institite, London, United Kingdom Institute of Ophthalmology, London, United Kingdom
OC9.2 The Human Orexin Receptor Type 2 Gene: Alternative promoters determining tissue-specific expression and identification of alternate splice variants and altered translational activities
Chen Jing, Randeva Harpal
University of Warwick, Medical School, Coventry, United Kingdom
OC9.3 Orexin-A Inhibits Glucagon Secretion And Proglucagon Gene Expression
Göncz Eva, Grötzinger Carsten, Theodoropoulou Marily, Wiedenmann Bertram, Strowski Mathias, Plöckinger Ursula
Charite, Medizinische Klinik mit Schwerpunkt Hepatologie, Gastroenterologie & Interdisziplinäres Stoffwechsel-Centrum/Endokrinologie und Diabetes mellitus, Campus Virchow-Klinikum, Berlin, Germany Max Planck Institut für Psychiatrie, München, Germany
OC9.4 Signalling And Internalisation Properies Of Corticotropin-Releasing Hormone (CRH) Receptor Type 2
Markovic Danijela, Lehnert Hendrik, Grammatopoulos Dimitris
Warwick Medical School, University of Warwick, Coventry, United Kingdom
OC9.5 The third intracellular loop of human SST5 is crucial for receptor internalization after SS28 stimulation
Peverelli Erika, Mantovani Giovanna, Lania Andrea G, Calebiro Davide, Doni Andrea, Bondioni Sara, Beck-Peccoz Paolo, Spada Anna
Endocrine Unit, Dpt. of Medical Sciences, Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena IRCCS, University of Milan, Milan, Italy Istituto Clinico Humanitas, Rozzano, Milan, Italy
OC9.6 Somatostatin receptor subtype-2 and -3 –selective agonists inhibit insulin secretion from INS-1 cells through modulation of the R-type Ca2+ channel activity
Mergler Stefan, Singh Vandana, Zacharias Sylvia, Wiedenmann Bertram, Plöckinger Ursula, Strowski Mathias
Hepatology & Gastroenterology, Berlin, Germany
OC9.7 Seven transmembrane receptors mediated actin cytoskeleton rearrangement: comparison with constitutively active mutants of G protein alpha-subunits
Hrovat Alenka, Frangez Robert, Pogacnik Azra, Vrecl Milka
Veterinary Faculty, University of Ljubljana, Ljubljana, Slovenia
     
10.55 - 12.35   Oral Communication 10: Obesity & Metabolism
Brown Hall
Chairs: L. Bajnok (Hungary) & F. Cavagnini (Italy)
OC10.1 The Selective Neuronal Deletion of Cannabinoid Type 1 Receptor is Still Able to Provide Resistance to Diet-Induced Obesity
Cervino Cristina, Cota Daniela, Bellocchio Luigi, Mancini Giacomo, Lutz Beat, Marsicano Giovanni, Pasquali Renato, Pagotto Uberto
Endocrine Unit and CRBA Hospital S.Orsola-Malpighi, Bologna, Italy Psychiatry Department, Cincinnati, United States Physiological Chemistry Department, Mainz, Germany Avenir INSERM , Bordeaux, France
OC10.2 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) mRNA expression in liver of patients with non-alcoholic steatohepatitis
Konopelska Sarah, Kienitz Tina, Pirlich Matthias, Bauditz Jürgen, Stewart Paul M., Lochs Herbert, Strasburger Christian J., Quinkler Marcus
Internal Medicine, Center for Gastroenterology, Hepatology and Endocrinology, Charite Campus Mitte, Charite Universitaetsmedizin Berlin, Berlin, Germany Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom
OC10.3 Selective leptin resistance within the brainstem of histamine deficient mice
Földes Anna, Márkus Veronika, Kovács Krisztina
Institute of Experimental Medicine, Budapest, Hungary
OC10.4 Restoration of signalling capabilities in total loss of function MC4R mutations
Brumm Harald, Bolze Florian, Friedel Susann, Hinney Anke, Klingenspor Martin, Hebebrand Johannes, Grüters Annette, Biebermann Heike
Charité Universitätsmedizin Berlin, Inst. Exp. Ped. Endocrinology, Berlin, Germany Phillipps-Universität, Inst. Biologie/Tierphysiologie, Marburg, Germany Rheinische Kliniken Essen, Universität Duisburg Essen, Klinik für Psychiatrie und Psychotherapie des Kinder- und Jugendalters, Essen, Germany
OC10.5 Mice lacking CRF receptor type 1 (CRFR1) have reduced vulnerability to diet-induced obesity
Diz-Chaves Yolanda, Monsaingeon Maud, Penicaud Luc, Ricquier Daniel, Contarino Angelo, Tabarin Antoine
Lab Nutrition et Neurosciences, Bordeaux, France Lab Neurobiologie et metabolisme , Toulouse, France Lab Metabolisme Mitochondrial , Paris, France
OC10.6 3-Iodothyronamine (T1AM) is a Novel Modulator of Metabolic Rate and Glucose Homeostasis
Grandy David K., Suchland Katherine L., Keck Thomas M., Yan Feifei, Shyng Show-Ling, Scanlan Thomas S.
Oregon Health & Science University, Portland, Oregon 97239, United States
OC10.7 Serum level of retinol binding protein 4 in obese individuals with insulin resistance and with 2 type diabetes mellitus treated by metformin
Tajtáková Mária, Semanová Zuzana, Ivancová Gabriela, Petrovicová Jozefína, Donicová Viera, Zemberová Eva
1st Department of Internal Medicine, University of P.I.Šafárik, Košice, Slovakia Departmet of Diabetes, Košice, Slovakia Institute of Medical Informatics, University of P.I. Šafárik, Košice, Slovakia RIA Laboratory, Košice, Slovakia
     
12.35 - 14.00   IPSEN Satellite Symposium - Expanding therapeutic armamentarium in Endocrinology
Orange Hall
Chairs: S. W. J. Lamberts (The Netherlands) & M. B. Ranke (Germany)
     
14.00 - 14.30   Poster session & Exhibition
Clinical Case Reports & Clinical Practice P473 - P518
Endocrine tumors & Neoplasia P139 - P178
Neuroendocrine & pituitary behaviour P563 - P610
Obesity & Metabolism P229 - P268
Reproduction P611 - P662

     
14.30 - 15.30   Meet the Expert 01 - Clinical: Graves' ophthalmopathy
Orange Hall
ME1 Choosing and timing treatment options in Graves' Orbitopathy (GO)
W. van den Bosch (The Netherlands)
ME1 Endocrine Orbitopathy
Cs. Balázs (Hungary)
     
14.30 - 15.30   Meet the Expert 02 - Clinical: Mineralocorticoid hypertension
Green Hall
ME2 Mineralocorticoid Hypertension
M. Mannelli (Italy)
     
14.30 - 15.30   Meet the Expert 03 - Basic to Clinical: Fetal programming by androgen excess
Blue Hall
ME3 Fetal programming by androgen excess
A. Tsatsoulis (Greece)
     
14.30 - 15.30   Meet the Expert 04 - Clinical: Intensive insulin treatment in ICU
Brown Hall
ME4 Intensive insulin treatment in ICU
T. Pieber (Austria)
     
14.30 - 15.30   Meet the Expert 05 - Clinical: Hirsutism
Room III
ME5 Hirsutism
B. O. Yildiz (Turkey)
     
14.30 - 15.30   Meet the Expert 06 - Clinical: Diagnosis of hypercortisolism
Plenary Hall
ME6 Differential diagnosis of hypercortisolism
M. Krsek (Czech Republic)
     
14.30 - 15.30   Meet the Expert 07 - Basic to Clinical: Endocrine disrupters
Room II
ME7 Endocrine disrupting chemicals: An emerging threat to public health?
H. Jarry (Germany)
     
14.30 - 15.30   Meet the Expert 08 - Basic: Mass spectrometry in endocrinology
Yellow Hall
ME8 Mass spectrometry in endocrinology
W. Fraser (United Kingdom)
     
15.30 - 16.00   Tea Break & Exhibition
     
16.00 - 17.45   Symposium 20 - Clinical: Thyroid
Plenary Hall
Chairs: A. Lewinski (Poland) & E. Martino (Italy)
16:00 S20.1 Updated guidelines for the follow-up of thyroid cancer. Martin J Schlumberger. Institut Gustave Roussy, 94805 Villejuif, France.
M. Schlumberger (France)
16:25 S20.2 Congenital Hypothyroidism with gland in situ
L. Persani (Italy)
16:50 S20.3 Thyroid and ageing Thyroid and ageing
I. Szabolcs (Hungary)
17:15 S20.4 Thyroid autoimmunity: genes and environment
P. S. Hansen (Germany)
     
16.00 - 17.45   Symposium 21 - Basic to Clinical: Pheromones, odorant and taste receptors
Orange Hall
Chairs: M. Coculescu (Romania) & M. Simoni (Germany)
16:00 S21.1 Odorant receptors and reproduction
H. Hatt (Germany)
16:25 S21.2 Molecular Architecture of Pheromone Sensing in Mammals
C. Dulac (USA)
16:50 S21.3 Endocrine and behavioural responses to pheromones
P. Brennan (United Kingdom)
17:15 S21.4 Bitter taste receptors and food intake
W. Meyerhof (Germany)
     
16.00 - 17.45   Oral Communication 11: Reproductive Endocrinology 2
Green Hall
Chair: S. Christin-Maitre (France) & T. Wenger (Hungary)
OC11.1 Hypogonadotrophic hypogonadism in mice lacking a functional Kiss-1 gene
d'Anglemont de Tassigny Xavier, Carlton Mark, Colledge William PDN,
University of Cambridge, Cambridge, United Kingdom Paradigm Therapeutics Ltd, Cambridge, United Kingdom
OC11.2 Leukemia inhibitory factor promotes the chemomigration of immature GnRH neurons
Dozio Elena, Ruscica Massimiliano, Cariboni Anna, Watanobe Hajime, Motta Marcella, Maggi Roberto, Magni Paolo
University of Milan, Milano, Italy University of Health and Welfare, Otawara, Japan
OC11.3 -Sex steroid and leptin regulation of KISS1/GPR54 system, a new regulator of the neuroendocrine reproductive axis, in human fetal GnRH-secreting neurons.
Morelli Annamaria, Marini Mirca, Mancina Rosa, Vignozzi Linda, Pezzatini Anna, Luconi Michaela, Mungai Sara, Fibbi Benedetta, Filippi Sandra, Vannelli Gabriella Barbara, Forti Gianni, Maggi Mario
University of Florence, Dept. Clinical Physiopathology, Andrology Unit, Florence, Italy University of Florence,Anatomy, Histology and Forensic Medicine, Florence, Italy University of Florence, Dept. Clinical Physiopathology, Endocrinology Unit, Florence, Italy University of Florence, 2Interdep. Lab of Functional and Cellular Pharmacology of Reproductio, Florence, Italy
OC11.4 EGFR ligands mediate key events of female reproduction: reduced litter size due to impaired fertilization in a transgenic mouse model
Schneider Marlon R., Gratao Ana A., Dahlhoff Maik, Sinowatz Fred, Wolf Eckhard
Institute of Molecular Animal Breeding and Biotechnology, University of Munich, Munich, Germany Institute of Veterinary Anatomy, University of Munich, Munich, Germany
OC11.5 Integration of the EGF network with early LH signal in preovulatory follicles
Panigone Sara, Hsieh Minnie, Persani Luca, Conti Marco
Lab Experimental Endocrinology, IRCCS Istituto Auxologico Italiano, University of Milan, Cusano Milanino, MI, Italy Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford, University School of Medicine, Stanford, CA, United States
OC11.6 Visceral fat amount as predictor for subclinical cardiovascular disease in women with Polycystic Ovary Syndrome
Cascella Teresa, Palomba Stefano, De Sio Ilario, Manguso Francesco, Vuolo Laura, Giallauria Francesco, Grieco Alessandra, Lombardi Gaetano, Colao Annamaria, Tafuri Domenico, Orio Francesco
Department of Molecular & Clinical Endocrinology and Oncology, “Federico II” University of Naples;, Naples, Italy Department of Obstetrics and Gynecology, University “Magna Graecia” of Catanzaro;, Catanzaro, Italy Department of Internal Medicine, Hepatology, and Gastroenterology, Second University of Naples;, Naples, Italy Gastroenterology Unit, “Cardarelli” Hospital, Naples;, Naples, Italy
OC11.7 The current definitions of the Metabolic Syndrome underestimate the prevalence of nascent metabolic abnormality in adolescents with PCOS.
Dewailly Didier, Catteau-Jonard Sophie, Reyss Anne-Céline
Lille University Hospital, Lille, France
     
16.00 - 17.45   Oral Communication 12: Diabetes
Brown Hall
Chairs: I. Klimes (Slovakia) & J. L. Medina (Portugal)
OC12.1 Hypoglycemia and Cerebral ATP Synthesis in Type 1 Diabetes
Mandl Martina, Zbyn Stefan, Mlynarik Vladimir, Promintzer Miriam, Luger Anton, Krebs Michael, Anderwald Christian, Bischof Martin G.
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria MR Center of Excellence, Medical University of Vienna, Vienna, Austria
OC12.2 Uncoupling protein 2 mutations – a new explanation for congenital hyperinsulinism?
Christesen Henrik Thybo, Hussain Khalid, Svargo Lone, Brock Jacobsen Bendt, Brusgaard Klaus
HC Andersen Children's Hospital, Odense, Denmark Dept. of Clinical Genetics, Odense University Hospital, Odense, Denmark London Center for Paediatric Endocrinology and Metabolism, Great Ormond Street Hospital, London, United Kingdom
OC12.3 Adhesion Molecules two years after Gestational Diabetes
Prikoszovich Thomas, Pacini Giovanni, Winzer Christine, Luger Anton, Wagner Oswald, Kautzky-Willer Alexandra
Medical University Vienna, Department of Internal Medicine III, Division of Endocrinology and Metabolism, Vienna, Austria Institute of Biomedical Engineering, CNR, Padova, Italy Medical University Vienna, Department of Medical and Chemical Laboratory Diagnostics, Vienna, Austria
OC12.4 Polymorphisms of PSMA6 gene and its adjacent genomic sites and their association with type II diabetes mellitus in the Latvian population
Poudziunas Ilva, Sjakste Tatjana, Kalis Martins, Lagzdins Maris, Pirags Valdis, Sjakste Nikolajs, Sokolovska Jelizaveta
University of Latvia, Riga, Latvia
OC12.5 The Influence of Concomitant Diabetes Mellitus on Mortality in Addison’s Disease
Bergthorsdottir Ragnhildur, Leonsson-Zachrisson Maria, Odén Anders, Johannsson Gudmundur
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden
OC12.6 Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in type 2 diabetic patients
Akalin Aysen, Temiz Gokhan, Akcar Nevbahar, Sensoy Banu
Osmangazi University Medical Faculty Department of Endocrinology, Eskisehir, Turkey Osmangazi University Medical Faculty Department of Internal Medicine , Eskisehir, Turkey Osmangazi University Medical Faculty Department of Radiology, Eskisehir, Turkey
OC12.7 A Propensity-Based Comparison of Haemodialysis and Peritoneal Dialysis among Diabetic Patients with End-Stage Renal Disease in the United States
O'Shea LA, Stack AG
Department of Renal Medicine, LGH, Co. Donegal, Ireland
     
17.45 - 18.30   Plenary Lecture 6
Plenary Hall
Chairs: X. Bertagna (France) & K. Racz (Hungary)
PL6 Initial work-up and long term follow-up in patients with pheochromocytomas and paragangliomas
P-F. Plouin (France)
     
18.:30 - 19.30   ESE Annual General Meeting
Plenary Hall
     
20.00 -    Hungarian Dinner
     

02/05/2007

08.00 - 08.45   Plenary Lecture 7
Plenary Hall
Chairs: C. Dieguez (Spain) & A. Milewicz (Poland)
PL7 Nuclear receptors. From molecular mechanisms to biological functions
A. Aranda (Spain)
     
08.45 - 10.25   Symposium 22 - Clinical: Bone
Plenary Hall
Chairs: G. Lombardi (Italy) & D. Vanderschueren (Belgium)
08:45 S22.1 Bisphosphonates: molecular mode of action and adverse effects
M. Rogers (United Kingdom)
09:10 S22.2 Calcimimetics in the Management of Hyperparathyroidism
M. Peacock (USA)
09:35 S22.3 Primary hyperparathyroidism: surgical approach and benefits
S. Adamek (Czech Republic)
10:00 S22.4 Osteoprotegerin-RANKL-RANK for clinical bone diseases
N. Franchimont (Switzerland)
     
08.45 - 10.25   Symposium 23 - Basic to Clinical: Reproductive endocrinology/andrology
Yellow Hall
Chairs: E. Nieschlag (Germany) & J. Toppari (Finland)
08:45 S23.1 Androgen Regulation of Spermatogenesis
P. Saunders (United Kingdom)
09:10 S23.2 The Experimental Mouse Model for Men with Klinefelter Syndrome
Y. Lue (USA)
09:35 S23.3 Genes involved in male infertility: sorting facts from fiction
E. Rajpert-De Meyts (Denmark)
10:00 S23.4 Genetic basis of testicular tumors
L. Looijenga (The Netherlands)
     
08.45 - 10.25   Symposium 24 - Basic to Clinical: Obesity
Orange Hall
Chairs: T. Horvath (USA) & Z. Liposits (Hungary)
08:45 S24.1 Altering adipocyte metabolism as a way to counteract obesity and insulin resistance
S. Enerbäck (Sweden)
09:10 S24.2 Triglyceride-lowering effect of metabolic switch in white adipose tissue
J. Kopecky (Czech Republic)
09:35 S24.3 Adipokines and insulin sensitivity in humans
J. M. Fernández-Real (Spain)
10:00 S24.4 Lipodistrophy and abdominal fat accumulation. New therapeutic alternatives
L. van Gaal (Belgium)
     
08.45 - 10.25   Symposium 25 - Basic to Clinical: Novel hormones
Green Hall
Chairs: A. Grueters (Germany) & J. Palvimo (Finland)
08:45 S25.1 Hormones help you living longer – the threat of Klotho
M. Kuro-o (USA)
09:10 S25.2 Phosphatonins and the Regulation of Renal Phosphate Transport
R. Kumar (USA)
09:35 S25.3 Correlation of Desoxypyridinolin and c – terminal telopeptide of collagen type I within different patient collectives
W. J. Faßbender (Germany)
10:00 S25.4 Hormonal regulation of iron homeostasis by Hepcidin
S. Vaulont (France)
     
10.25 - 10.55   Coffee Break & Exhibition
     
10.55 - 11.40   ESE Young Investigators Award Presentation
Sponsored by NOVARTIS
Plenary Hall
Chairs: E. Ghigo (Italy) & S. W. J. Lamberts (The Netherlands)
Investigation of the role of MRAP in the functional expression of the melanocortin 2 receptor
S. Cooray (United Kingdom)
[123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience
S. Hahner (Germany)
Adrenal lesions in multiple endocrine neoplasia type 1: data from the french group for the study of endocrine tumor (GTE)
B. Gatta (France)
Effect of GH receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in acromegalic patients resistant to somatostatin analogues
M. C. De Martino (Italy)
Neuropilin-2 and its ligands are involved in the migration of GnRH-secreting neurons
A. Cariboni (Italy)
Prevalence of inactivating TSH receptor (TSHR) mutations in a large series of pediatric subjects with non-autoimmune mild hyper-thyrotropinemia (hyperTSH)
D. Cordella (Italy)
     
11.40 -    Closing Ceremony
Plenary Hall
     

ESE AGM
The next AGM of the European Society of Endocrinology will be held at 18.30-19.30 on Tuesday 1 May 2007 in Plenary Lecture Hall, Papp Lászlό Budapest Sportaréna, H-1143 Budapest, Stefánia út 2. Hungary. To request a copy of the draft agenda please contact the ESE Secretariat on info@euro-endo.org